Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2020
December 2020, Vol 11, No 6
December 2020, Vol 11, No 6
Economics and Inequities in Cancer Care: AVBCC Keynote Address
AVBCC 2020 Summit
December 2020, Vol 11, No 6
Greg Simon, JD, led the Cancer Moonshot program for the Obama administration, raising $1.8 billion in new funding for cancer research and the development of new cancer programs. In 2017, Joe Biden called on him to serve as President of the Biden Cancer Initiative. Mr Simon is also a survivor of chronic lymphocytic leukemia, a consultant and public speaker at Simonovation, LLC, and one of the thought leaders in cancer care.
Read Article
Recruiting Minorities to Clinical Trials
AVBCC 2020 Summit
December 2020, Vol 11, No 6
The COVID-19 pandemic has exposed many of the cracks in our healthcare system. According to Maurie Markman, MD, MS, FACP, FASCO, President, Medicine and Science, Cancer Treatment Centers of America, COVID-19 disproportionately affects the elderly, those with comorbidities, and racial and ethnic minority populations, all of whom are more likely to have serious or fatal illness. At the 10th Annual Summit of the Association for Value-Based Cancer Care (AVBCC) in 2020, Dr Markman served as a co-moderator of a session about minority representation in clinical trials.
Read Article
Expert Insights on Innovation in the Oncology Pipeline
AVBCC 2020 Summit
December 2020, Vol 11, No 6
Total growth in the oncology pipeline in 2020 has been driven by targeted therapies, said Doug Long, Vice President, Industry Relations, IQVIA, at the 10th Annual Summit of the Association for Value-Based Cancer Care (AVBCC) in 2020.
Read Article
New Research Highlights Barriers to Clinical Trial Participation
By
Chase Doyle
Clinical Trials
December 2020, Vol 11, No 6
Enrollment in clinical trials is vital for the advancement of knowledge and improvement of patient outcomes, but few adults participate in cancer clinical trials. The numbers are even lower among minority adolescent and young adults (AYAs).
Read Article
Explosion of Treatment Regimens for Multiple Myeloma: Selecting the Right Option for the Right Patient
By
Phoebe Starr
Multiple Myeloma
,
NCCN 2020 Hematologic Malignancies
December 2020, Vol 11, No 6
At the 2020 NCCN hematologic malignancies conference, multiple myeloma expert Shaji Kumar, MD, Consultant and Professor of Medicine, Division of Hematology, Mayo Clinic Cancer Center, Rochester, MN, discussed the “bonanza of treatment regimens for multiple myeloma.”
Read Article
Aggressive Approach to High-Risk Smoldering Myeloma Gains Consensus
By
Phoebe Starr
NCCN 2020 Hematologic Malignancies
December 2020, Vol 11, No 6
Although smoldering myeloma is acknowledged as a clinical entity, debate continues about whether to treat, when to treat, and how to treat this condition, said Natalie S. Callander, MD, Leader, Myeloma/Lymphoma Disease-Oriented Team, University of Wisconsin Carbone Cancer Center, Madison, at the 2020 NCCN hematologic malignancies conference.
Read Article
Industry Leaders Look Ahead to a New Administration
AVBCC 2020 Summit
December 2020, Vol 11, No 6
Healthcare and biopharmaceutical industry markets were trending positively during the immediate aftermath of the 2020 election, even before the promising news from Pfizer and Moderna regarding their COVID-19 vaccines. At the 10th Annual Summit of the Association for Value-Based Cancer Care (AVBCC) in 2020, 2 industry leaders advised that the industry reaction was likely in response to an expectation of less volatility and more predictability in healthcare in 2021 with what is likely to be divided government.
Read Article
FoundationOne CDx Approved as Companion Diagnostic for Vitrakvi to Identify NTRK Fusions in Solid Tumors
FDA Approvals, News & Updates
December 2020, Vol 11, No 6
On
October 23, 2020
, the FDA approved the FoundationOne CDx diagnostic test as a companion diagnostic to identify fusions in the
NTRK1
,
NTRK2
, and
NTRK3
genes in patients who are eligible for treatment with larotrectinib (Vitrakvi).
Read Article
FDA Expands FoundationOne Liquid CDx Indications for Several Mutations in Various Cancers
FDA Approvals, News & Updates
December 2020, Vol 11, No 6
In October and November, the FDA approved FoundationOne Liquid CDx (Foundation Medicine), a next-generation sequencing liquid biopsy test, for the identification of multiple cancers and biomarkers.
Read Article
Opdivo plus Yervoy First Immunotherapy Approved for Unresectable Malignant Pleural Mesothelioma
FDA Approvals, News & Updates
,
Mesothelioma
December 2020, Vol 11, No 6
On
October 2, 2020
, the FDA approved the combination of nivolumab (Opdivo; Bristol Myers Squibb), a PD-1 inhibitor, and ipilimumab (Yervoy; Bristol Myers Squibb), a CTLA-4 inhibitor, for first-line treatment of adults with unresectable malignant pleural mesothelioma.
Read Article
Page 2 of 4
1
2
3
4
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
Talvey Receives Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma